Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Developing regions such as Sub-Saharan Africa, Latin America, and the Caribbean showed particularly alarming numbers ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, ...

Globally, the burden of sugar-sweetened beverage consumption was found to be greater among men than women, as well as among ...

A new study analyzed data from 2.9 million individuals across 118 countries and found that consumption of sugar-sweetened ...

Micronutrient deficiencies, such as low vitamin D and magnesium, are alarmingly common in people with type 2 diabetes, ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...